Published: 15 December 2023
Author(s): Rafael Moreno-González, Josep Maria Cruzado, Andrea Corsonello, Paolo Fabbietti, Lisanne Tap, Francesco Mattace-Raso, Johan Ärnlöv, Axel C. Carlsson, Agnieszka Guligowska, Tomasz Kostka, Rada Artzi-Medvedik, Itshak Melzer, Regina Roller-Wirnsberger, Gerhard Wirnsberger, Robert Kob, Cornel Sieber, Fabrizia Lattanzio, Francesc Formiga, SCOPE investigators
Issue: May 2024
Section: Original Article

Sarcopenia has been drawing growing attention in recent years, with a rapidly increasing number of research studies being performed in this field. The establishment of an International Classification of Diseases (ICD-10-CM) code for sarcopenia in 2016 enables its recognition as a distinct skeletal muscle disease. Moreover, the recent guideline update for sarcopenia definition and diagnosis in 2018, the European Working Group on Sarcopenia in Older People (EWGSOP2) consensus [1], provides specific cut-off points for each defining parameter and emphasizes screening and assessment with a practical algorithm for clinical use.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.